본문으로 건너뛰기
← 뒤로

High-grade follicular B-cell lymphoma-associated C3 rapidly progressive glomerulonephritis: a rare association.

BMJ case reports 2026 Vol.19(3)

Vazquez Urrutia JR, Strong AL, Malysz J, Annageldiyev C, Abendroth C, Naik S

📝 환자 설명용 한 줄

Rapidly progressive glomerulonephritis (GN) in the context of B-cell lymphoma is rare, with most cases involving diffuse-large B-cell lymphoma or marginal zone lymphoma.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Vazquez Urrutia JR, Strong AL, et al. (2026). High-grade follicular B-cell lymphoma-associated C3 rapidly progressive glomerulonephritis: a rare association.. BMJ case reports, 19(3). https://doi.org/10.1136/bcr-2025-269217
MLA Vazquez Urrutia JR, et al.. "High-grade follicular B-cell lymphoma-associated C3 rapidly progressive glomerulonephritis: a rare association.." BMJ case reports, vol. 19, no. 3, 2026.
PMID 41839518

Abstract

Rapidly progressive glomerulonephritis (GN) in the context of B-cell lymphoma is rare, with most cases involving diffuse-large B-cell lymphoma or marginal zone lymphoma. Kidney biopsies are infrequently performed in this population, further limiting diagnostic clarity. Here, we report a case of newly diagnosed follicular large B-cell lymphoma (FLBCL) presenting with a nephritic syndrome, characterised by haematuria, hypertension and heavy proteinuria, caused by C3 crescentic GN, requiring dialysis. The patient was treated with polatuzumab, bendamustine and rituximab, which was well tolerated. Renal function gradually improved, leading to dialysis discontinuation, coinciding with lymphoma remission. This case underscores the atypical presentation of FLBCL, including renal dysfunction as an early manifestation, and the importance of prompt diagnosis and targeted therapy.

MeSH Terms

Humans; Glomerulonephritis; Rituximab; Lymphoma, Follicular; Bendamustine Hydrochloride; Male; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Middle Aged; Complement C3